American Portfolios Advisors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$15.4K Hold
1,204
﹤0.01% 2315
2022
Q2
$12.5K Hold
1,204
﹤0.01% 2462
2022
Q1
$16.4K Hold
1,204
﹤0.01% 2473
2021
Q4
$15.9K Sell
1,204
-25
-2% -$315 ﹤0.01% 2419
2021
Q3
$9.72K Hold
1,229
﹤0.01% 2580
2021
Q2
$8.44K Sell
1,229
-350
-22% -$2.16K ﹤0.01% 2597
2021
Q1
$9.63K Hold
1,579
﹤0.01% 2399
2020
Q4
$4.94K Hold
1,579
﹤0.01% 2421
2020
Q3
$4.03K Hold
1,579
﹤0.01% 2366
2020
Q2
$3.6K Hold
1,579
﹤0.01% 2349
2020
Q1
$1.66K Buy
1,579
+590
+60% +$1.99K ﹤0.01% 2452
2019
Q4
$3.61K Hold
989
﹤0.01% 2401
2019
Q3
$3.6K Hold
989
﹤0.01% 2310
2019
Q2
$4.14K Hold
989
﹤0.01% 2241
2019
Q1
$3.52K Hold
989
﹤0.01% 2208
2018
Q4
$2.19K Buy
989
+639
+183% +$2.64K ﹤0.01% 2116
2018
Q3
$2.24K Hold
350
﹤0.01% 2214
2018
Q2
$2.61K Buy
+350
New +$2.63K ﹤0.01% 2155

Other funds holding CLMT

American Portfolios Advisors's CLMT Position: Q3 2022 in Review

American Portfolios Advisors held its Calumet Specialty Products (CLMT) position steady in Q3 2022 at 1,204 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2315.

American Portfolios Advisors first reported a position in CLMT in Q2 2018 and has held it in 18 quarters since. The position peaked at $16.4K in Q1 2022. 62 funds tracked by Wall St. Rank hold CLMT as of Q3 2022.

  • American Portfolios Advisors held 1,204 shares of Calumet Specialty Products worth $15.4K as of Q3 2022.
  • American Portfolios Advisors left its Calumet Specialty Products share count unchanged in Q3 2022.
  • Calumet Specialty Products made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2315 holding.
  • American Portfolios Advisors first reported a position in Calumet Specialty Products in Q2 2018 and has held it in 18 quarters since.
  • American Portfolios Advisors's Calumet Specialty Products position peaked at $16.4K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.